848500-12-9 Usage
Uses
Used in Pharmaceutical Industry:
(6'-BroMo-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-carbaMic acid tert-butyl ester, 98+% C15H22BrN3O2, MW: 356.27 is used as an intermediate in the synthesis of pharmaceutical compounds due to its unique chemical structure and reactivity. Its bromine atom and carboxylic acid group can be utilized in various chemical reactions to form new compounds with potential therapeutic properties.
Used in Chemical Research:
(6'-BroMo-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-carbaMic acid tert-butyl ester, 98+% C15H22BrN3O2, MW: 356.27 is used as a research compound in chemical laboratories for studying its properties, reactivity, and potential applications. Its unique structure and functional groups make it an interesting subject for research in organic chemistry and related fields.
Used in Material Science:
(6'-BroMo-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-carbaMic acid tert-butyl ester, 98+% C15H22BrN3O2, MW: 356.27 can be used in the development of new materials with specific properties. Its unique structure and functional groups can be exploited to create materials with tailored characteristics for various applications, such as sensors, catalysts, or advanced materials for electronics and energy storage.
Check Digit Verification of cas no
The CAS Registry Mumber 848500-12-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,5,0 and 0 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 848500-12:
(8*8)+(7*4)+(6*8)+(5*5)+(4*0)+(3*0)+(2*1)+(1*2)=169
169 % 10 = 9
So 848500-12-9 is a valid CAS Registry Number.
848500-12-9Relevant articles and documents
2,4'-BIPYRIDINYL COMPOUNDS AS PROTEIN KINASE D INHIBITORS USEFUL FOR THE TREATMENT OF IA HEART FAILURE AND CANCER
-
Page/Page column 179, (2010/01/07)
The present invention provides novel organic compounds of Formula I: methods of use, and pharmaceutical compositions thereof.